According to our latest study, the global Solid-phase Oligonucleotide Synthesis market size was valued at USD 433.2 million in 2023 and is forecast to a readjusted size of USD 1230 million by 2030 with a CAGR of 16.1% during review period.
The publisher report includes an overview of the development of the Solid-phase Oligonucleotide Synthesis industry chain, the market status of Commercial (Primers, Probes), Academic Research (Primers, Probes), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Solid-phase Oligonucleotide Synthesis.
Regionally, the report analyzes the Solid-phase Oligonucleotide Synthesis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Solid-phase Oligonucleotide Synthesis market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Solid-phase Oligonucleotide Synthesis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Solid-phase Oligonucleotide Synthesis industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Primers, Probes).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Solid-phase Oligonucleotide Synthesis market.
Regional Analysis: The report involves examining the Solid-phase Oligonucleotide Synthesis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Solid-phase Oligonucleotide Synthesis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Solid-phase Oligonucleotide Synthesis:
Company Analysis: Report covers individual Solid-phase Oligonucleotide Synthesis players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Solid-phase Oligonucleotide Synthesis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Commercial, Academic Research).
Technology Analysis: Report covers specific technologies relevant to Solid-phase Oligonucleotide Synthesis. It assesses the current state, advancements, and potential future developments in Solid-phase Oligonucleotide Synthesis areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Solid-phase Oligonucleotide Synthesis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Solid-phase Oligonucleotide Synthesis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Market segment by Application
Commercial
Academic Research
Market segment by players, this report covers
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Solid-phase Oligonucleotide Synthesis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Solid-phase Oligonucleotide Synthesis, with revenue, gross margin and global market share of Solid-phase Oligonucleotide Synthesis from 2019 to 2024.
Chapter 3, the Solid-phase Oligonucleotide Synthesis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Solid-phase Oligonucleotide Synthesis market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Solid-phase Oligonucleotide Synthesis.
Chapter 13, to describe Solid-phase Oligonucleotide Synthesis research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Solid-phase Oligonucleotide Synthesis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Solid-phase Oligonucleotide Synthesis by Type
1.3.1 Overview: Global Solid-phase Oligonucleotide Synthesis Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Type in 2023
1.3.3 Primers
1.3.4 Probes
1.3.5 Intermediate-scale Synthesis Oligos
1.3.6 Large-scale Synthesis Oligos
1.3.7 Linkers and Adaptors
1.4 Global Solid-phase Oligonucleotide Synthesis Market by Application
1.4.1 Overview: Global Solid-phase Oligonucleotide Synthesis Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Commercial
1.4.3 Academic Research
1.5 Global Solid-phase Oligonucleotide Synthesis Market Size & Forecast
1.6 Global Solid-phase Oligonucleotide Synthesis Market Size and Forecast by Region
1.6.1 Global Solid-phase Oligonucleotide Synthesis Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Solid-phase Oligonucleotide Synthesis Market Size by Region, (2019-2030)
1.6.3 North America Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2019-2030)
1.6.4 Europe Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2019-2030)
1.6.6 South America Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Genescript
2.1.1 Genescript Details
2.1.2 Genescript Major Business
2.1.3 Genescript Solid-phase Oligonucleotide Synthesis Product and Solutions
2.1.4 Genescript Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Genescript Recent Developments and Future Plans
2.2 GeneArt (Thermofischer)
2.2.1 GeneArt (Thermofischer) Details
2.2.2 GeneArt (Thermofischer) Major Business
2.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product and Solutions
2.2.4 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GeneArt (Thermofischer) Recent Developments and Future Plans
2.3 Renesas Electronics Corporation
2.3.1 Renesas Electronics Corporation Details
2.3.2 Renesas Electronics Corporation Major Business
2.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product and Solutions
2.3.4 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Renesas Electronics Corporation Recent Developments and Future Plans
2.4 DNA 2.0 (ATUM)
2.4.1 DNA 2.0 (ATUM) Details
2.4.2 DNA 2.0 (ATUM) Major Business
2.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product and Solutions
2.4.4 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 DNA 2.0 (ATUM) Recent Developments and Future Plans
2.5 OriGene
2.5.1 OriGene Details
2.5.2 OriGene Major Business
2.5.3 OriGene Solid-phase Oligonucleotide Synthesis Product and Solutions
2.5.4 OriGene Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 OriGene Recent Developments and Future Plans
2.6 BBI
2.6.1 BBI Details
2.6.2 BBI Major Business
2.6.3 BBI Solid-phase Oligonucleotide Synthesis Product and Solutions
2.6.4 BBI Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 BBI Recent Developments and Future Plans
2.7 Genewiz
2.7.1 Genewiz Details
2.7.2 Genewiz Major Business
2.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Product and Solutions
2.7.4 Genewiz Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Genewiz Recent Developments and Future Plans
2.8 Eurofins Genomics
2.8.1 Eurofins Genomics Details
2.8.2 Eurofins Genomics Major Business
2.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product and Solutions
2.8.4 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Eurofins Genomics Recent Developments and Future Plans
2.9 Gene Oracle
2.9.1 Gene Oracle Details
2.9.2 Gene Oracle Major Business
2.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Product and Solutions
2.9.4 Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Gene Oracle Recent Developments and Future Plans
2.10 SBS Genetech
2.10.1 SBS Genetech Details
2.10.2 SBS Genetech Major Business
2.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Product and Solutions
2.10.4 SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 SBS Genetech Recent Developments and Future Plans
2.11 Bio Basic
2.11.1 Bio Basic Details
2.11.2 Bio Basic Major Business
2.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Product and Solutions
2.11.4 Bio Basic Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bio Basic Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Solid-phase Oligonucleotide Synthesis Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Solid-phase Oligonucleotide Synthesis by Company Revenue
3.2.2 Top 3 Solid-phase Oligonucleotide Synthesis Players Market Share in 2023
3.2.3 Top 6 Solid-phase Oligonucleotide Synthesis Players Market Share in 2023
3.3 Solid-phase Oligonucleotide Synthesis Market: Overall Company Footprint Analysis
3.3.1 Solid-phase Oligonucleotide Synthesis Market: Region Footprint
3.3.2 Solid-phase Oligonucleotide Synthesis Market: Company Product Type Footprint
3.3.3 Solid-phase Oligonucleotide Synthesis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Consumption Value and Market Share by Type (2019-2024)
4.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Application (2019-2024)
5.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Application (2025-2030)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2019-2030)
6.2 North America Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2019-2030)
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country
6.3.1 North America Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2019-2030)
6.3.2 United States Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
6.3.3 Canada Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
6.3.4 Mexico Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2019-2030)
7.2 Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2019-2030)
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country
7.3.1 Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2019-2030)
7.3.2 Germany Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
7.3.3 France Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
7.3.5 Russia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
7.3.6 Italy Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region
8.3.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Region (2019-2030)
8.3.2 China Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
8.3.3 Japan Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
8.3.4 South Korea Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
8.3.5 India Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
8.3.7 Australia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
9 South America
9.1 South America Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2019-2030)
9.2 South America Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2019-2030)
9.3 South America Solid-phase Oligonucleotide Synthesis Market Size by Country
9.3.1 South America Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2019-2030)
9.3.2 Brazil Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
9.3.3 Argentina Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country
10.3.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2019-2030)
10.3.2 Turkey Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
10.3.4 UAE Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Solid-phase Oligonucleotide Synthesis Market Drivers
11.2 Solid-phase Oligonucleotide Synthesis Market Restraints
11.3 Solid-phase Oligonucleotide Synthesis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Solid-phase Oligonucleotide Synthesis Industry Chain
12.2 Solid-phase Oligonucleotide Synthesis Upstream Analysis
12.3 Solid-phase Oligonucleotide Synthesis Midstream Analysis
12.4 Solid-phase Oligonucleotide Synthesis Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
听
听
*If Applicable.
